Results 151 to 160 of about 18,337 (203)

Impact of tumor necrosis factor-alpha and lysophosphatidic acid on the behavior of ovarian cancer cells in a three-dimensional collagen hydrogel. [PDF]

J Obstet Gynaecol Res
Tino AB, Dachs GU, Sykes PH, Chitcholtan K.   +3 more
europepmc   +1 more source

Inflammatory milieu and role of epigenetic modifications in high-grade serous ovarian cancer. [PDF]

Clin Epigenetics
Pradhan S, Kabekkodu SP, Eswaran S, Kumar NAN, Upadhya D, Chakrabarty S, Devi V.   +6 more
europepmc   +1 more source

Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147⁺ extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma. [PDF]

Int J Biol Sci
Qian L, Fu Z, Chen P, Guo Y, Li Y, Wang Y, Wang B, Zhang Q, Guo Q, Wu L, Kucharzewska P, Chen Z, Piao Y, Zhang S.   +13 more
europepmc   +1 more source

Lipoprotein(a) and the Vascular Redox Interface: Linking Arteriosclerosis, Thrombosis, and Vascular Biology. [PDF]

Arterioscler Thromb Vasc Biol
Zubiran R, Remaley AT.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Autotaxin Facilitates Selective LPA Receptor Signaling

SSRN Electronic Journal, 2022
SUMMARYAutotaxin (ATX; ENPP2) produces the lipid mediator lysophosphatidic acid (LPA) that signals through disparate EDG (LPA1-3) and P2Y (LPA4-6) G protein-coupled receptors. ATX/LPA promote several (patho)physiological processes, including in pulmonary fibrosis, thus serving as attractive drug targets.
Fernando Salgado-Polo, Razvan Borza, Florence Marsais, Catherine Jagerschmidt, Ludovic Waeckel, Wouter H. Moolenaar, Paul Ford, Bertrand Heckmann, Anastassis Perrakis   +8 more
openaire   +1 more source